Home Cart Sign in  
Chemical Structure| 284028-89-3 Chemical Structure| 284028-89-3

Structure of XAV-939
CAS No.: 284028-89-3

Chemical Structure| 284028-89-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

XAV-939 is a Tankyrase inhibitor used as an auxiliary agent in cell therapy.

Synonyms: NVP-XAV939

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of XAV-939

CAS No. :284028-89-3
Formula : C14H11F3N2OS
M.W : 312.31
SMILES Code : O=C1C(CSCC2)=C2N=C(C3=CC=C(C(F)(F)F)C=C3)N1
Synonyms :
NVP-XAV939
MDL No. :MFCD16879017
InChI Key :KLGQSVMIPOVQAX-UHFFFAOYSA-N
Pubchem ID :135418940

Safety of XAV-939

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H320-H335
Precautionary Statements:P264-P270-P301+P312-P330

Related Pathways of XAV-939

epigenetics
DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
BT-549 5 μM 48 h Inhibition of cell proliferation PMC4228255
HCC-1143 5 μM 48 h Inhibition of cell proliferation PMC4228255
OPCs 0.5 μM 3 days XAV-939 significantly rescued Mbp expression and OL morphology in the Eed null OL lineage PMC8070886
MDA-MB-231 5 μM 48 h Inhibition of cell proliferation PMC4228255
HCC-1937 5 μM 48 h Inhibition of cell proliferation PMC4228255
Human pluripotent stem cell-derived GnRH neurons 10 µM 10 days To investigate the effect of Wnt signaling inhibition on GnRH neuron differentiation, it was found that Wnt inhibition significantly improved the differentiation efficiency of GnRH neurons PMC9806769
Pancreatic progenitor cells 5 µM 4 days To inhibit the WNT signaling pathway and study its effect on the differentiation of FOXA2-deficient pancreatic progenitor cells. The results showed that WNT inhibition partially reversed the phenotype associated with FOXA2 deficiency. PMC7817686
Mouse epiblast stem cells (EpiSCs) 10 µM XAV-939 promotes the stable maintenance of EpiSCs by inhibiting the Wnt signaling pathway and reducing spontaneous differentiation. PMC4400648
Mouse oligodendrocyte progenitor cells 0.01 or 0.1μM 24 h Increased levels of both Axin2 and Axin1 proteins, promoted oligodendrocyte differentiation PMC3145042
Fibroblasts 10 µM DPC-Exos attenuated the inhibitory effect of XAV939, leading to an increase in the expression levels of these molecules. PMC11264511
Fibroblasts 10 µM XAV939 significantly inhibited the proliferation and migration of fibroblasts, suggesting that blocking the Wnt/β-catenin signaling pathway could hinder the activity of fibroblasts. PMC11264511

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Mkx+/- mouse Achilles tendon injury model Local injection 4 µM Single administration, observed for 28 or 52 days XAV-939 improved tendon regeneration in mice by inhibiting the Wnt/β-Catenin signaling pathway, reducing fibrosis and angiogenesis, and enhancing biomechanical properties. PMC9678895
Mouse Spinal cord demyelination model Spinal cord injection 0.1μM Single injection, duration of 6 days Accelerated oligodendrocyte progenitor cell differentiation and myelin regeneration PMC3145042
Mice Full-thickness skin excision model Intraperitoneal injection 1.25 mg/kg Four injections on day 1 After treatment with XAV939, wound closure was significantly slower compared to other groups, suggesting that blocking the Wnt/β-catenin signaling pathway could impede wound healing. Specifically, the wound closure rate and the number of new HFs in DPC-Exos + X group was significantly reduced compared to the DPC-Exos group, which suggested that blocking the Wnt/β-catenin signaling pathway could inhibit the promoting effects of DPC-Exos on wound healing and HF regeneration. PMC11264511

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.20mL

0.64mL

0.32mL

16.01mL

3.20mL

1.60mL

32.02mL

6.40mL

3.20mL

References

 

Historical Records

Categories